22 related articles for article (PubMed ID: 11420841)
1. Anaphylaxis to Patent Blue V: a case series.
Manson AL; Juneja R; Self R; Farquhar-Smith P; Macneill F; Seneviratne SL
Asia Pac Allergy; 2012 Jan; 2(1):86-9. PubMed ID: 22348211
[TBL] [Abstract][Full Text] [Related]
2. Severe anaphylactic reaction after blue dye injection for sentinel lymph node biopsy in breast surgery: Report of two cases and literature review.
Frountzas M; Theodoropoulos C; Karathanasis P; Nikolaou C; Zografos CG; Larentzakis A; Zografos GC; Michalopoulos NV
Clin Case Rep; 2021 Jul; 9(7):. PubMed ID: 34322237
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
4. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
5. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers.
Tousimis E; Van Zee KJ; Fey JV; Hoque LW; Tan LK; Cody HS; Borgen PI; Montgomery LL
J Am Coll Surg; 2003 Oct; 197(4):529-35. PubMed ID: 14522317
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR
Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737
[TBL] [Abstract][Full Text] [Related]
7. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in early breast cancer surgery--working with the risks of vital blue dye to reap the benefits.
White V; Harvey JR; Griffith CD; Youssef M; Carr M
Eur J Surg Oncol; 2011 Feb; 37(2):101-8. PubMed ID: 21195576
[TBL] [Abstract][Full Text] [Related]
10. Status of sentinel lymph node for breast cancer.
Moncayo VM; Aarsvold JN; Grant SF; Bartley SC; Alazraki NP
Semin Nucl Med; 2013 Jul; 43(4):281-93. PubMed ID: 23725990
[TBL] [Abstract][Full Text] [Related]
11. [Sentinel lymph node biopsy in breast cancer: a validation study and preliminary results].
Nissan A; Spira RM; Chisin R; Zamir O; Prus D; Klein M; Badriyyah M; Freund HR
Harefuah; 2001 Jun; 140(6):468-70, 567. PubMed ID: 11420841
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
